Latest Europe News

AVITA Medical reported an 18% revenue increase in Q3 2025 driven by new product launches and deeper market penetration, while continuing to face net losses and credit covenant challenges. The company also announced a CEO departure and interim leadership appointment.

AVITA Medical reported a 13% drop in Q3 commercial revenue to $17.1 million but improved its net loss and secured CE Mark approval for RECELL GO in Europe, signaling strategic shifts ahead.

Neuren Pharmaceuticals reported a milestone quarter with DAYBUE net sales reaching US$101.1 million, driving a 24% jump in royalty income. The expanding patient base and community physician uptake signal strong growth ahead.

ABx Group has achieved over 98% retention of rare earth elements with near-complete impurity removal in large batch tests from its Deep Leads project, advancing toward delivering its first mixed rare earth carbonate sample by November’s end.

Eclipse Metals has completed over 700 metres of diamond drilling at its Grønnedal project in Greenland, confirming continuous rare earth mineralisation and reinforcing its substantial inferred resource estimate. Drilling has now progressed to the polymetallic Ivigtût prospect, broadening the company’s critical minerals footprint.

Sarytogan Graphite Limited has secured a $1.4 million top-up placement from the European Bank for Reconstruction and Development, reinforcing confidence in its graphite project and supporting its feasibility study timeline.

Sweden’s Parliament has voted to overturn its uranium mining ban, effective January 2026, paving the way for Aura Energy to fully develop its polymetallic Häggån project with uranium extraction now permitted.

Battery Age Minerals has initiated a targeted reconnaissance and sampling program at the Apex Germanium-Gallium Project in Utah, marking the first modern exploration in decades at this historically significant site. The move expands their strategic critical metals footprint across the US and Europe.

Altech Batteries reveals Sodium-Nickel-Chloride (SNC) batteries achieve an exceptionally low failure rate of 0.6-1.5% over 15+ years in harsh South African conditions, significantly outperforming lithium-ion and lead-acid alternatives.

ReNerve Limited is scaling up its clinical trial for the NervAlign® Nerve Cuff following promising interim results that show significant pain reduction in nerve repair patients. The expanded study aims to solidify evidence for broader regulatory approval and market adoption.

Goodman Group reports robust progress in Q1 FY26 with a $12.4 billion development pipeline dominated by data centres, reaffirming a 9% operating EPS growth forecast. The group is advancing logistics automation and expanding data centre capacity across key global markets.

Woodside Energy Group unveiled an ambitious growth strategy at its 2025 Capital Markets Day, targeting a net operating cash flow of around US$9 billion by the early 2030s, driven by key LNG and ammonia projects.